ASX
Telix Pharmaceuticals
TLX:ASX•Healthcare
Sensitive ASX Announcement
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded
Published: 14/10/25, 04:31pm (AEST)•5 pages